The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Growth In Market Size Of The Cross-Species Organ Transplantation Market During 2026–2030?
The market for cross-species organ transplantation has experienced significant growth over recent years. This market is projected to expand from $15.2 billion in 2025 to $16.5 billion by 2026, showing a compound annual growth rate (CAGR) of 8.5%. Historically, this expansion has been driven by factors such as the scarcity of human donor organs, initial research efforts in xenotransplantation, improvements in genetic engineering technologies, the preclinical assessment of animal-sourced organs, and the rising number of individuals on transplant waiting lists.
The cross-species organ transplantation market is anticipated to experience robust growth in the coming years. This market is expected to expand to $22.65 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.2%. The projected growth is largely due to increased clinical trial activity in xenotransplantation, a rise in investment for gene-edited animal models, growing collaborations between biotech firms and transplant centers, advancements in immunosuppressive therapies, and the expansion of regulatory frameworks for xenotransplants. Key trends during this forecast period include ongoing progress in genetically engineered donor organs, an increasing focus on strategies to mitigate immune rejection, the broader adoption of organ preservation and perfusion technologies, a surge in investment for translational xenotransplant research, and enhanced regulatory and ethical oversight.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp
What Core Drivers Are Transforming The Cross-Species Organ Transplantation Market?
The increasing adoption of genetic engineering is projected to boost the expansion of the cross-species organ transplantation market in the future. Genetic engineering involves the intentional alteration of an organism’s DNA through biotechnological methods to insert, delete, or modify particular genes. The surge in genetic engineering stems from the pressing requirement to tackle organ scarcity by developing animal organs that are better suited for human transplants. It facilitates the expansion of cross-species organ transplantation by allowing for the alteration of animal organs to minimize immune rejection, thereby rendering them appropriate for human transplants. As an illustration, in July 2023, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated 247 gene therapies were in Phase II by the close of the first quarter of 2023, rising by 5% to achieve 260 by the close of the second quarter. Consequently, the expanding adoption of genetic engineering is fueling the growth of the cross-species organ transplantation market.
What Segment Types Are Included In The Cross-Species Organ Transplantation Market Analysis?
The cross-species organ transplantation market covered in this report is segmented –
1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types
2) By Application: Kidney, Heart, Liver, Lung, Other Applications
3) By End-User: Transplant Centers, Hospitals, Other End-Users
Subsegments:
1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions
2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays
3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants
4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices
Which Trends Are Guiding The Development Of The Cross-Species Organ Transplantation Market?
Major companies within the cross-species organ transplantation market are concentrating on forming strategic partnerships to expedite the regulatory approval process for xenotransplantation solutions. A strategic partnership represents an alliance where entities cooperate to reach shared objectives by utilizing each other’s strengths and resources, aiming to stimulate growth, innovation, and competitiveness without merging. For example, in February 2025, United Therapeutics, a US-based biotechnology company, and eGenesis, a US-based pharmaceutical company, commenced clinical trials for pig kidney (xenotransplant) transplants in humans. This trial secured approval from the U.S. Food and Drug Administration (FDA) allowing the transplantation of genetically modified pig kidneys into patients experiencing kidney failure. The objective of these trials is to address the severe shortage of donor kidneys by potentially providing a new, sustainable organ source for those in need.
Which Organizations Are Operating Within The Cross-Species Organ Transplantation Market?
Major companies operating in the cross-species organ transplantation market are Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc., Revivicor Inc., XVIVO Perfusion AB, Bridge To Life Ltd, Transplant Genomics Inc.
Access The Complete Cross-Species Organ Transplantation Market Report:
Which Region Commands The Largest Share Of The Cross-Species Organ Transplantation Market?
North America was the largest region in the cross-species organ transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Cross-Species Organ Transplantation Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=27267&type=smp
Browse Through More Reports Similar to the Global Cross-Species Organ Transplantation Market 2026, By The Business Research Company
Crohns Disease Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Inflammatory Bowel Disease Treatment Global Market Report 2026
Rare Inflammatory Disease Treatment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
